Medtech Investment Outlook: In Health Care You Don’t Become A Unicorn Overnight
The pandemic has shaken up investor priorities and changed the outlook for health care start-ups – or has it? Nooman Haque managing director, life sciences and healthcare at Silicon Valley Bank, gives his view of what has changed over the past year, and looks at future trends.
You may also be interested in...
One year on, we’ve seen how the coronavirus prompted entrepreneurial instincts to surface in the medtech and healthtech sectors. Asia healthtech investor specialist HealthXCapital tells Medtech Insight about the changes that are likely to stick as in an industry that has seen the value of rapid responsiveness to acute need.
COVID has necessitated a refresh of NHS England’s Long Term Plan, which must double down on concepts such as at-home, patient-empowered care and virtual wards, says the NHS Confederation.
The UK MedTech Directorate has issued its much-awaited medical technology strategy for improving supply resilience and encouraging innovative and dynamic markets and sector diversity.